The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
Open accessAbstract
The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocarditis (HE) in a large multi-national cohort. Patients hospitalized with definite or possible infective endocarditis by the International Collaboration on Endocarditis Prospective Cohort Study in 64 hospitals from 28 countries were included and characteristics of HE patients compared with IE due to other pathogens. Of 5591 patients enrolled, 77 (1.4%) had HE. HE was associated with a younger age (47 vs. 61 years; p<0.001), a higher prevalence of immunologic/vascular manifestations (32% vs. 20%; p<0.008) and stroke (25% vs. 17% p = 0.05) but a lower prevalence of congestive heart failure (15% vs. 30%; p = 0.004), death in-hospital (4% vs. 18%; p = 0.001) or after 1 year follow-up (6% vs. 20%; p = 0.01) than IE due to other pathogens (n = 5514). On multivariable analysis, stroke was associated with mitral valve vegetations (OR 3.60; CI 1.34-9.65; p<0.01) and younger age (OR 0.62; CI 0.49-0.90; p<0.01). The overall outcome of HE was excellent with the in-hospital mortality (4%) significantly better than for non-HE (18%; p<0.001). Prosthetic valve endocarditis was more common in HE (35%) than non-HE (24%). The outcome of prosthetic valve and native valve HE was excellent whether treated medically or with surgery. Current treatment is very successful for the management of both native valve prosthetic valve HE but further studies are needed to determine why HE has a predilection for younger people and to cause stroke. The small number of patients and observational design limit inferences on treatment strategies. Self selection of study sites limits epidemiological inferences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Self-citationContemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang, A. (2007) · JAMA · doi:10.1001/jama.297.12.1354 · Cited by 703 · cited 5×
“However in PVE the requirement for surgery was lower (30%) which compares favourably with published rates for PVE overall (49%) [12,27].”
BackgroundResultInfluentialDickerman, S. A., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., Doco-Lecompte, T., Eisen, D. P., Fortes, C. Q., Fowler, V. G., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.023 · Cited by 374 · cited 1×
“aureus endocarditis (20%) and viridans streptococcal IE (8%) in the ICE cohort [29].”
BackgroundSelf-citationA Systematic Review of Population-Based Studies of Infective Endocarditis
Tleyjeh, I. M., Abdel-Latif, A., Rahbi, H., Scott, C. G., Bailey, K. R., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2007) · Chest · doi:10.1378/chest.06-2048 · Cited by 324
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277
Chu, V. H., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñoz, P., et al. (2009) · Heart · doi:10.1136/hrt.2008.152975 · Cited by 109
Self-citation
Research works printed but not linked: 23
- PI Lerner, 1966, Infective endocarditis in the antibiotic era, N Engl J, Med274, 199, 10.1056/NEJM196601272740407 · DOI · Paper page
- LL Pelletier, 1977, Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963–72, Medicine, 56, 287, 10.1097/00005792-197707000-00002 · DOI · Paper page
- C Selton-Suty, 2012, Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey, Clin Infect Dis, 54, 1230, 10.1093/cid/cis199 · DOI · Paper page
- E Ferreiros, 2006, EIRA-2 Investigators. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la RepúblicamArgentina-2 (EIRA-2) Study, Am Heart J, 151, 545, 10.1016/j.ahj.2005.04.008 · DOI
- IM Tleyjeh, 2005, Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota, JAMA, 293, 3022, 10.1001/jama.293.24.3022 · DOI · Paper page
- P Brouqui, 2001, Endocarditis due to rare and fastidious bacteria, Clin Microbiol Rev, 14, 177, 10.1128/CMR.14.1.177-207.2001 · DOI · Paper page
- M Das, 1997, Infective endocarditis caused by HACEK microorganisms, Ann Rev Med, 48, 25, 10.1146/annurev.med.48.1.25 · DOI · Paper page
- C Darras-Joly, 1997, Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group, Clin Infect, Dis24, 1087, 10.1086/513624 · DOI
- AN Malani, 2006, Cardiobacterium hominis endocarditis: Two cases and a review of the literature, Eur J Clin Microbiol Infect, Dis25, 587, 10.1007/s10096-006-0189-9 · DOI
- L Paturel, 2004, Actinobacillus actinomycetemcomitans endocarditis, Clinical Microbiol Infect, 10, 98, 10.1111/j.1469-0691.2004.00794.x · DOI · Paper page
- JS Li, 2000, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, 30, 633, 10.1086/313753 · DOI · Paper page
- ND Friedman, 2002, Healthcare associated blood stream infections in adults, Ann Intern Med, 137, 791
- SA Hunt, 2005, ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice, Circulation, 112, e154
- HP Adams Jr, 1994, Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association, Circulation, 90, 1588, 10.1161/01.CIR.90.3.1588 · DOI
- VH Chu, 2005, Repeat infective endocarditis: differentiating relapse from reinfection, Clin Infect Dis, 41, 406, 10.1086/431590 · DOI
- ZA Kanafani, 2010, Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults, Eur J Clin Microbiol Infect Dis, 29, 1203, 10.1007/s10096-010-0983-2 · DOI
- N Fernández-Hidalgo, 2011, Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital. Prospective analysis of referral bias and influence of inadequate antimicrobial treatment, Clin Microbiol Infect, 17, 769, 10.1111/j.1469-0691.2010.03314.x · DOI
- HP Lawrence, 2008, Oral health-related quality of life in a birth cohort of 32-year olds, Community Dent Oral Epidemiol, 36, 305, 10.1111/j.1600-0528.2007.00395.x · DOI
- B Hoen, 2002, Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France, JAMA, 288, 75, 10.1001/jama.288.1.75 · DOI · Paper page
- D Horstkotte, 2004, Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology, Eur Heart J, 25, 267, 10.1016/j.ehj.2003.11.008 · DOI · Paper page
- PL Lu, 2000, Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis, J Clin Microbiol, 38, 2015, 10.1128/JCM.38.5.2015-2017.2000 · doi:10.1128/jcm.38.5.2015-2017.2000
- S Okazaki, 2011, Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis, Cerebrovasc Dis, 32, 483, 10.1159/000331475 · DOI
- C Paschalis, 1990, Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis, Eur Neurol, 30, 87, 10.1159/000117317 · DOI
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Management Considerations in Infective Endocarditis: A Review
Wang, A., Gaca, J. G., & Chu, V. H. (2018) · JAMA · doi:10.1001/jama.2018.7596 · Cited by 368
Self-citationChurch, D. L., Cerutti, L., Gürtler, A., Griener, T., Zelazny, A., & Emler, S. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00053-19 · Cited by 349
Nørskov-Lauritsen, N. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-13 · Cited by 260
Metadata
- Authors
- Chambers, S. T., Murdoch, D., Morris, A., Holland, D., Pappas, P., Almela, M., Fernández-Hidalgo, N., Almirante, B., Bouza, E., Forno, D., Rio, A. D., Hannan, M. M., Harkness, J., Kanafani, Z. A., Lalani, T., Lang, S., Raymond, N., Read, K., Vinogradova, T., Woods, C. W., Wray, D., Corey, G. R., Chu, V. H., & International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-17
- Volume
- 8
- Issue
- 5
- Pages
- e63181
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2146605413
- Cited by
- 237
- References
- 8
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.